L Ornithine L Aspartate is used to treat liver diseases including acute and chronic hepatitis, chronic alcoholic liver damage, fatty liver, jaundice, liver cirrhosis, and non-alcoholic steatohepatitis (non-alcoholic fatty liver disease). Liver diseases lead to disturbance of vital liver functions. It is grouped under the following drug class(es): Amino Acids. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Hepamerz, Orparan, Ormeta and Hepa-Merz. Its PubChem CID is 10220941.
L-Ornithine L-Aspartate
| CAS No | 3230-94-2 |
|---|---|
| Molecular Formula | C5H12N2O2.C4H7NO4 |
| Molecular Weight | 265.26 g/mol |
| Synonyms | (2S)-2-aminobutanedioic acid;(2S)-2,5-diaminopentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
L Ornithine L Aspartate is used to treat liver diseases including acute and chronic hepatitis, chronic alcoholic liver damage, fatty liver, jaundice, liver cirrhosis, and non-alcoholic steatohepatitis (non-alcoholic fatty liver disease).
The listed CAS number is 3230-94-2.
The listed molecular formula is C5H12N2O2.C4H7NO4.
The listed molecular weight is 265.26 g/mol.
(2S)-2-aminobutanedioic acid;(2S)-2,5-diaminopentanoic acid.
The source lists Hepamerz, Orparan, Ormeta and Hepa-Merz.